# Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

> **NCT00393718** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 400 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** liraglutide
- **DRUG:** glibenclamide
- **DRUG:** placebo
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00393718
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-11
- **Final completion:** 2008-05
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2017-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00393718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00393718, "Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00393718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*